Home » Topics » BioWorld Science

BioWorld Science
RSS

Zithromax approved by FDA for new indication

June 28, 1996

U.S. development of DS-4152 for Kaposi's sarcoma treatment discontinued

June 28, 1996

Sequus' Caelyx approved by European Commission

June 28, 1996

Hybridon's GEM-132 to undergo clinical trials

June 28, 1996

Remune covered under Finnish patent

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Lidak's Lidakol undergoes phase III trials

June 28, 1996

CSL to distribute OraVax's HNK20

June 28, 1996

Antifungal agents revealed by Merck & Co.

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...